Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation

Human term placenta and other postpartum-derived biological tissues are promising sources of perinatal cells with unique stem cell properties. Among the massive current research on stem cells, one medical focus on easily available stem cells is to exploit them in the design of immunotherapy protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Paris, Francesca, Pizzuti, Valeria, Marrazzo, Pasquale, Pession, Andrea, Alviano, Francesco, Bonsi, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738084/
https://www.ncbi.nlm.nih.gov/pubmed/36498923
http://dx.doi.org/10.3390/ijms232314597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738084/
https://www.ncbi.nlm.nih.gov/pubmed/36498923
http://dx.doi.org/10.3390/ijms232314597

Ejemplares similares